Skip to main content

Find Clinical Trials

Home
Conditions
Neurocutaneous Syndromes

Clinical trial condition

Neurocutaneous Syndromes

Explore clinical trials studying Neurocutaneous Syndromes. Study availability and eligibility vary by location and protocol.

351 public trials 65 recruiting studies

Refine in advanced search Browse all conditions

Neurocutaneous Syndromes trial results

Completed

Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1

NCT03090971

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cutaneous Neurofibroma, Genetic Diseases, Inborn, +14 more
Locations: Fundação Educacional Serra dos Órgãos - UNIFESO Teresópolis, Rio de Janeiro, Brazil

View Trial Details

Completed

Study About Annoucement of the Diagnosis of Neurofibromatosis 1 in de Novo Forms

NCT03298438

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diagnoses Disease, Genetic Diseases, Inborn, +19 more
Locations: CHRU de Brest Brest, France

View Trial Details

Completed

Neurofibromatosis Type 1 Patient Registry

NCT01410006

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations: Washington University St Louis, Missouri, United States

View Trial Details

Completed

Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

NCT01419639

Conditions: Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +35 more
Locations: New York University Medical Center New York, United States

View Trial Details

Completed

Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas

NCT01140360

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +16 more
Locations: Riley Hospital for Children Indianapolis, Indiana, United States

View Trial Details

Completed

Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

NCT00089765

Conditions: Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +15 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Metabolic Mapping to Measure Retinal Metabolism

NCT00385333

Conditions: Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +19 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) Patients

NCT01490476

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +29 more
Locations: Hôpital Beaujon, 100 boulevard du Général Leclerc Clichy, France

View Trial Details

Completed

Neurofibromatosis Type 1 Brain Tumor Genetic Risk

NCT01707836

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +15 more
Locations: Washington University St Louis, Missouri, United States

View Trial Details

Completed

Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis

NCT03140449

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Facial Angiofibroma, +13 more
Locations: Not specified

View Trial Details